First Time Loading...
B

Beijing SL Pharmaceutical Co Ltd
SZSE:002038

Watchlist Manager
Beijing SL Pharmaceutical Co Ltd
SZSE:002038
Watchlist
Price: 8.62 CNY 0.12% Market Closed
Updated: May 2, 2024
Section:
 

Relative Value

The Relative Value of one Beijing SL Pharmaceutical Co Ltd stock under the Base Case scenario is 8 CNY. Compared to the current market price of 8.62 CNY, Beijing SL Pharmaceutical Co Ltd is Overvalued by 7%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
8 CNY
Overvaluation 7%
Relative Value
Price
B
Worst Case
Base Case
Best Case

Valuation Multiples

8.9
P/S
P/S
Price to Sales
8.9
vs History
30
vs Industry
50
Median 3Y
8.6
Median 5Y
8.4
Industry
8.1
Forward
7.6
More Details
28.2
P/E
P/E
Price to Earnings
28.2
vs History
44
vs Industry
6
Median 3Y
26.9
Median 5Y
27.4
Industry
26.2
Forward
36.8
More Details
25.9
P/OCF
P/OCF
Price to OCF
25.9
vs History
26
vs Industry
6
Median 3Y
22.7
Median 5Y
22.7
Industry
22.6
More Details
63.8
P/FCFE
P/FCFE
Price to FCFE
63.8
vs History
25
vs Industry
3
Median 3Y
44.7
Median 5Y
44.7
Industry
21.3
More Details
1.6
P/B
P/B
Price to Book Value
1.6
vs History
92
vs Industry
52
Median 3Y
1.8
Median 5Y
2
Industry
2.5
More Details
7.5
EV/S
EV/S
Enterprise Value to Sales
7.5
vs History
42
vs Industry
44
Median 3Y
7.5
Median 5Y
7.3
Industry
7.3
Forward
6.4
More Details
9.2
EV/GP
EV/GP
Enterprise Value to Gross Profit
9.2
vs History
36
vs Industry
42
Median 3Y
8.8
Median 5Y
8.8
Industry
9.1
More Details
43.2
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
43.2
vs History
39
vs Industry
3
Median 3Y
41.4
Median 5Y
41
Industry
4.4
More Details
43.2
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
43.2
vs History
39
vs Industry
3
Median 3Y
41.4
Median 5Y
41
Industry
4.3
More Details
21.8
EV/OCF
EV/OCF
Enterprise Value to OCF
21.8
vs History
30
vs Industry
8
Median 3Y
19.4
Median 5Y
19.9
Industry
5.4
More Details
53.8
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
53.8
vs History
28
vs Industry
3
Median 3Y
38.5
Median 5Y
38.7
Industry
3.2
More Details
1.7
EV/IC
EV/IC
Enterprise Value to IC
1.7
vs History
90
vs Industry
53
Median 3Y
2
Median 5Y
2.1
Industry
5
More Details

Multiples Across Competitors

Competitors Multiples
Beijing SL Pharmaceutical Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Beijing SL Pharmaceutical Co Ltd
SZSE:002038
8.9B CNY 8.9 28.2 43.2 43.2
US
Abbvie Inc
NYSE:ABBV
281.3B USD 5.2 58.4 12.7 19.4
US
Amgen Inc
NASDAQ:AMGN
148.1B USD 5.3 22 16.4 24.5
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
103.8B USD 10.5 28.7 23 24
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
101.7B USD 7.8 25.7 17.2 18.9
AU
CSL Ltd
ASX:CSL
133B AUD 6.1 35.1 21.3 26.4
US
Gilead Sciences Inc
NASDAQ:GILD
81.1B USD 3 167.6 6.7 8.8
US
Moderna Inc
NASDAQ:MRNA
45.8B USD 6.7 -9.7 -10.4 -8.9
US
Seagen Inc
NASDAQ:SGEN
43.1B USD 18.8 -57.5 -61.9 -55.8
US
Biogen Inc
NASDAQ:BIIB
31.3B USD 3.2 26.8 13.8 17.2
KR
Celltrion Inc
KRX:068270
38.9T KRW 17.9 72.5 44.4 61.1

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 133,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.